Generated: December 12, 2017
DrugPatentWatch Database Preview
Nizatidine - Generic Drug Details
« Back to Dashboard
What are the generic drug sources for nizatidine and what is the scope of nizatidine patent protection?
is the generic ingredient in three branded drugs marketed by Smithkline Beecham, Ani Pharms Inc, Apotex Inc, Dr Reddys Labs Ltd, Glenmark Generics, Mylan Pharms Inc, Sandoz, Watson Labs, Braintree, Amneal Pharms, and Pfizer, and is included in thirteen NDAs. There is one patent protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.
Nizatidine has two patent family members in two countries.
There are seven drug master file entries for nizatidine. Nineteen suppliers are listed for this compound.
Pharmacology for nizatidine
Medical Subject Heading (MeSH) Categories for nizatidine
|Ani Pharms Inc||NIZATIDINE||nizatidine||CAPSULE;ORAL||075668-002||Sep 12, 2002||AB||RX||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Pfizer||AXID AR||nizatidine||TABLET;ORAL||020555-001||May 9, 1996||OTC||Yes||Yes||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Smithkline Beecham||AXID||nizatidine||CAPSULE;ORAL||019508-002||Apr 12, 1988||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Dr Reddys Labs Ltd||NIZATIDINE||nizatidine||CAPSULE;ORAL||077314-001||Sep 15, 2005||AB||RX||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Ani Pharms Inc||NIZATIDINE||nizatidine||CAPSULE;ORAL||075461-001||Jul 8, 2002||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Mylan Pharms Inc||NIZATIDINE||nizatidine||CAPSULE;ORAL||075806-001||Jul 5, 2002||AB||RX||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Amneal Pharms||NIZATIDINE||nizatidine||SOLUTION;ORAL||090576-001||Nov 18, 2009||RX||No||Yes||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Glenmark Generics||NIZATIDINE||nizatidine||CAPSULE;ORAL||090618-002||Jul 15, 2011||AB||RX||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Mylan Pharms Inc||NIZATIDINE||nizatidine||CAPSULE;ORAL||075934-002||Jul 9, 2002||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Smithkline Beecham||AXID||nizatidine||CAPSULE;ORAL||019508-001||Apr 12, 1988||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
Expired Orange Book Patents for Generic Ingredient: nizatidine
International Patent Family for Ingredient: nizatidine
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws,
it is advisable to have patent counsel verify freedom to operate.
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.